These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1090 related items for PubMed ID: 28429651

  • 1. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW, de Vries JK, Mulder DJ, Kamphuisen PW.
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [Abstract] [Full Text] [Related]

  • 2. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E, Rittner SS, Carroll JE, Crawford PM, Dant L, Laws R, Leo MC, Puro J, Persell SD.
    J Am Heart Assoc; 2017 Jul 03; 6(7):. PubMed ID: 28673901
    [Abstract] [Full Text] [Related]

  • 3. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
    Hamoui O, Omar MI, Raal FJ, Rashed W, Kane A, Alami M, Abreu P, Mashhoud W, Alsheikh-Ali AA.
    BMC Cardiovasc Disord; 2019 Mar 15; 19(1):61. PubMed ID: 30876390
    [Abstract] [Full Text] [Related]

  • 4. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T, Zhou S, Anzalone D, Kern DM, Tunceli O, Cziraky MJ, Willey VJ.
    J Am Heart Assoc; 2017 May 04; 6(5):. PubMed ID: 28473405
    [Abstract] [Full Text] [Related]

  • 5. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
    Persell SD, Brown T, Lee JY, Shah S, Henley E, Long T, Luther S, Lloyd-Jones DM, Jean-Jacques M, Kandula NR, Sanchez T, Baker DW.
    Circ Cardiovasc Qual Outcomes; 2015 Nov 04; 8(6):560-6. PubMed ID: 26555123
    [Abstract] [Full Text] [Related]

  • 6. Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort.
    Schonmann Y, Bleich O, Matalon A, Yeshua H.
    Eur J Prev Cardiol; 2018 May 04; 25(8):870-880. PubMed ID: 29517367
    [Abstract] [Full Text] [Related]

  • 7. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA, Bushnik T, Manuel DG, Anderson TJ.
    J Am Heart Assoc; 2015 Jul 14; 4(7):. PubMed ID: 26175357
    [Abstract] [Full Text] [Related]

  • 8. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J, Rajalingam T, Fossella J, Zhou H, Eisenberg N, Roche-Nagle G.
    Ann Vasc Surg; 2020 Nov 14; 69():197-205. PubMed ID: 32554202
    [Abstract] [Full Text] [Related]

  • 9. Utility of 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines in HIV-Infected Adults With Carotid Atherosclerosis.
    Phan BAP, Weigel B, Ma Y, Scherzer R, Li D, Hur S, Kalapus SC, Deeks S, Hsue P.
    Circ Cardiovasc Imaging; 2017 Jul 14; 10(7):e005995. PubMed ID: 28674084
    [Abstract] [Full Text] [Related]

  • 10. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
    Del Ben M, Baratta F, Polimeni L, Pastori D, Loffredo L, Averna M, Violi F, Angelico F.
    Nutr Metab Cardiovasc Dis; 2017 Feb 14; 27(2):161-167. PubMed ID: 27914698
    [Abstract] [Full Text] [Related]

  • 11. Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial Infarction.
    Miedema MD, Garberich RF, Schnaidt LJ, Peterson E, Strauss C, Sharkey S, Knickelbine T, Newell MC, Henry TD.
    J Am Heart Assoc; 2017 Apr 12; 6(4):. PubMed ID: 28404560
    [Abstract] [Full Text] [Related]

  • 12. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA, Möhlenkamp S, Lehmann N, Kälsch H, Dykun I, Pundt N, Moebus S, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study Investigators.
    JACC Cardiovasc Imaging; 2017 Feb 12; 10(2):143-153. PubMed ID: 27665163
    [Abstract] [Full Text] [Related]

  • 13. Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia.
    O'Donnell TFX, Deery SE, Darling JD, Shean KE, Mittleman MA, Yee GN, Dernbach MR, Schermerhorn ML.
    J Vasc Surg; 2017 Aug 12; 66(2):572-578. PubMed ID: 28506476
    [Abstract] [Full Text] [Related]

  • 14. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
    Laleman N, Henrard S, van den Akker M, Goderis G, Buntinx F, Van Pottelbergh G, Vaes B.
    BMC Cardiovasc Disord; 2018 Nov 06; 18(1):209. PubMed ID: 30400778
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
    Bai JW, Boulet G, Halpern EM, Lovblom LE, Eldelekli D, Keenan HA, Brent M, Paul N, Bril V, Cherney DZ, Weisman A, Perkins BA.
    Cardiovasc Diabetol; 2016 Jan 25; 15():14. PubMed ID: 26809442
    [Abstract] [Full Text] [Related]

  • 16. Sex Differences in the Use of Statins in Community Practice.
    Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, Virani SS, Wilson PWF, Louie MJ, Koren A, Li Z, Peterson ED, Navar AM.
    Circ Cardiovasc Qual Outcomes; 2019 Aug 25; 12(8):e005562. PubMed ID: 31416347
    [Abstract] [Full Text] [Related]

  • 17. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Miedema MD, Dardari ZA, Kianoush S, Virani SS, Yeboah J, Knickelbine T, Sandfort V, Rodriguez CJ, Nasir K, Blaha MJ.
    J Am Heart Assoc; 2018 Jun 13; 7(12):. PubMed ID: 29899017
    [Abstract] [Full Text] [Related]

  • 18. Adherence to guidelines to prevent cardiovascular diseases: The LifeLines cohort study.
    Balder JW, Scholtens S, de Vries JK, van Schie LM, Boekholdt SM, Hovingh GK, Kamphuisen PW, Kuivenhoven JA.
    Neth J Med; 2015 Aug 13; 73(7):316-23. PubMed ID: 26314714
    [Abstract] [Full Text] [Related]

  • 19. Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort.
    Rhee EJ, Park SE, Oh HG, Park CY, Oh KW, Park SW, Blankstein R, Plutzky J, Lee WY.
    Atherosclerosis; 2015 May 13; 240(1):242-9. PubMed ID: 25818250
    [Abstract] [Full Text] [Related]

  • 20. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž, De Backer G, Fras Z, Kotseva K, Tokgözoglu L, Wood D, De Bacquer D, EUROASPIRE Investigators.
    Atherosclerosis; 2016 Mar 13; 246():243-50. PubMed ID: 26812002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.